We recently published an article titled Jim Cramer on Super Micro Computer and Other Stocks. In this article, we are going to ...

Shares slipped in New York and Europe Thursday as the latest US inflation report strengthened the case for a slower pace of ...

The FTSE 100 index traded up 25.77 points, 0.3%, at 8,269.51. The FTSE 250 slipped 12.69 points, 0.1%, at 20,809.69, and the AIM All-Share down just 0.19 of a point at 736.47.

Johnson & Johnson said on Monday it has discontinued a late-stage study testing its experimental drug to treat a type of ...

Since Camellya is the only new 5-star unit in this update, the other event banner will likely be a rerun banner. Luckily, a recent leak from a reliable source hints at the return of a popular 5 ...

With the third quarter of 2024 ending, the discourse on the stock market for global equities has shifted back to interest ...

Please verify your email address. Wuthering Waves reveals the RPG's newest gacha banners for the game's upcoming 1.3 update, featuring multiple new characters. Shorekeeper will headline the first ...

Please verify your email address. Xilonen, Chiori, Nahida, and Hu Tao are the featured characters in Genshin Impact Version 5.1 Event Banners. Xilonen offers healing ...

A PROCESSION celebrated the role women played in Barrow's industrial heritage by 'reclaiming the past.' A colourful parade through the town centre marked the end of the Barrow Dreams week on ...

Sept 18 (Reuters) - British drugmaker GSK (GSK.L), opens new tab said on Wednesday it had agreed to settle two lawsuits in California that claimed its discontinued heartburn drug Zantac caused cancer.

This summer, GSK cut its yearly vaccine sales projection on the back of a narrowed recommendation for adult respiratory syncytial virus (RSV) vaccines from the Centers for Disease Control and ...

GSK has demonstrated robust sales growth, with a 13% increase to GBP 7.9 billion and a core operating profit up by 21% to GBP 2.5 billion, as noted by CEO Emma Walmsley in the latest earnings call.